Expert Guidance to Optimize Adjuvant Therapy Decisions for HER2+ Early-Stage Breast Cancer: A CCO ClinicalImpact Program

Use CCO’s adjuvant breast cancer treatment decision tool to optimize clinical management of patients with EBC in your practice and review an expert-authored activity providing an overview of adjuvant therapy for HER2+ EBC and download the associated slideset. Gain expert perspectives on challenges in managing HER2+ EBC in 3 ClinicalThought commentaries.

Share

Program Content

Activities

Identifying High-Risk Disease
In HER2-Positive Early Breast Cancer, Who Benefits From Dual HER2-Targeted Therapy? Identifying High-Risk Disease
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 17, 2018

Expires: October 16, 2019

Activities

Optimizing Tx for HER2+ EBC
Optimizing Adjuvant Therapy Decisions for HER2-Positive Early Breast Cancer
Case Challenge
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 07, 2018

Expires: November 06, 2019

Faculty

cover img faculity

Mark D. Pegram, MD

Leonard M. Miller School of Medicine
University of Miami
Miami, Florida

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Genentech TEXT Only

Partners

GRACE

ProCE Banner